EGFR mutation-positive NSCLC: factors to consider when deciding first-line therapy.

Introduction: Advanced non-small-cell lung cancers with EGFR mutation belong to the models of solid tumors which revealed the concept of oncogene addiction. For that reason, first, second and third...